Adhesive for Drug Delivery System Market Size was valued at USD xx Billion in 2023. The Adhesive for Drug Delivery System industry is projected to grow from USD xx Billion in 2024 to USD xx Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.50% during the forecast period (2024 - 2032). Increased demand for transdermal drug delivery is the key market driver enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Growing investments in research and development are driving the market growth
Market CAGR for adhesives for drug delivery systems is being driven by growing investments in research and development. In the realm of pharmaceutical prowess, biotechnology brilliance, and scholarly sagacity, resources are being meticulously channeled toward the crafting of cutting-edge adhesive concoctions. These formulations, endowed with a plethora of enhancements, ranging from superior skin adhesion to meticulously controlled drug release and mitigated skin irritation, represent the vanguard of adhesive evolution. This concerted investment thrust propels the relentless exploration of uncharted territories in material marvels, manufacturing methodologies, and application modalities, thereby birthing a cornucopia of adhesive innovations. Simultaneously, the hallowed halls of research and development echo with fervent endeavors aimed at unraveling the mysteries of unmet clinical exigencies, fortifying patient adherence, and fortifying the efficacy of drug delivery systems. The fertile nexus between burgeoning scientific enlightenment and technological wizardry in adhesive research and development galvanizes the market, fostering the genesis of safer, swifter, and savvier medication delivery solutions.
At the fulcrum of this transformative tide lies the burgeoning clamor for transdermal drug delivery, a veritable juggernaut propelling the market towards unprecedented heights. The ascendancy of transdermal patches, bedecked with a myriad of merits, including their non-invasive nature, intuitive application, and peerless patient compliance, serves as the lodestar guiding this paradigm shift. Crucially, adhesive mastery assumes center stage in ensuring the seamless adherence of these patches to the skin, orchestrating a delicate symphony of drug release and therapeutic efficacy.
As the clarion call for transdermal triumph reverberates louder, propelled by the siren song of administrative convenience and the promise of gastrointestinal respite, a concomitant surge in the quest for adhesive excellence ensues. Manufacturers, cognizant of this clarion call, funnel their resources into the crucible of research and development, endeavoring to imbue adhesives with unparalleled skin affinity, limberness, and biocompatibility. This inexorable surge in demand for transdermal drug delivery systems serves as the centrifugal force propelling the adhesive for the drug delivery system market towards unparalleled innovation and exuberant expansion.
Increasing investments in healthcare R&D are propelling the growth of the market by fostering innovation and technological advancements. Pharmaceutical companies, biotechnology firms, and research institutions are allocating resources to develop novel adhesive formulations that enhance drug delivery efficacy, patient comfort, and adherence. These investments support the exploration of new materials, manufacturing processes, and application techniques, leading to the introduction of advanced adhesive products with improved properties such as enhanced skin adhesion and controlled drug release kinetics. Furthermore, R&D initiatives focus on addressing unmet clinical needs and expanding the applicability of adhesive-based drug delivery systems across various therapeutic areas. As a result, the growing body of scientific knowledge and technological innovations in adhesive R&D contributes to the expansion of adhesives in the drug delivery system market, driving market growth and development. For instance, Henkel unveiled fresh offerings, including Loctite Liofol LA 7818 RE / 6231 RE and Loctite Liofol LA 7102 RE / 6902 RE, aimed at advancing recyclability within the packaging sector.
The Adhesive for Drug Delivery System market segmentation, based on Resin Type, includes Acrylic, Polyisobutylene, Silicone, and Others. In 2023, the Acrylic segment dominated the market, accounting for 35% of market revenue due to their favorable characteristics, such as excellent adhesion to various substrates, including skin, and compatibility with a wide range of drugs. Additionally, acrylic adhesives offer good mechanical properties, moisture resistance, and biocompatibility, making them suitable for transdermal and other drug delivery applications. Their versatility and reliability have contributed to acrylic resins capturing the largest market share in the market.
Polyisobutylene (PIB) resin type is experiencing the highest compound annual growth rate (CAGR) in the adhesive for drug delivery system market due to its unique properties. PIB adhesives offer excellent flexibility, tackiness, and low permeability to gases and moisture. These characteristics make them well-suited for transdermal patches and other drug delivery applications where a flexible and occlusive adhesive is required. The increasing demand for such applications, coupled with the superior properties of PIB resin, is driving its rapid growth in the market.
Figure 1: Adhesive for Drug Delivery System Market, by Resin Type, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The Adhesive for Drug Delivery System market segmentation, based on Technology, includes Hydration-Mediation Adhesion, Bonding-Mediation Adhesion, Receptor-Mediation Adhesion, and others. In 2023, the Hydration-Mediation Adhesion category generated the most income due to its exceptional performance in maintaining strong adhesion under moist conditions, such as those encountered on the skin. This technology leverages the hydration of specific adhesive components to enhance their adhesive properties, ensuring secure attachment of drug delivery systems while minimizing skin irritation. Its ability to provide reliable adhesion in diverse environmental conditions has propelled hydration-mediated adhesion technology to capture the largest market share.
Bonding-mediated adhesion technology is experiencing the highest compound annual growth rate (CAGR) in the market due to its innovative approach to facilitating adhesion. This technology relies on specific bonding agents to enhance adhesion between the adhesive and the substrate, resulting in improved bonding strength and durability. With its ability to overcome challenges related to substrate variability and compatibility, bonding-mediated adhesion technology is increasingly favored for drug delivery applications, driving its rapid growth in the market.
By region, the study provides the market insights into North America, Europe, Asia-Pacific, and the Rest of the World. North America has secured the largest market share in the adhesive for drug delivery system market due to several factors. These include the region's well-established healthcare infrastructure, significant investments in research and development, and high adoption rates of advanced medical technologies. Moreover, robust regulatory frameworks and favorable reimbursement policies in North America support the development and commercialization of innovative adhesive-based drug delivery systems. These factors collectively contribute to North America's dominance in the market.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.
Figure 2: Adhesive For Drug Delivery System Market Share By Region 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Adhesive for Drug Delivery System market accounts for the second-largest market share due to the strong emphasis on research and development. Europe has attained the second-largest market share in the market owing to several factors. These include the region's advanced healthcare systems, strong emphasis on research and development, and a high prevalence of chronic diseases. Additionally, Europe boasts a well-established pharmaceutical industry and a supportive regulatory environment that encourages the adoption of innovative drug delivery technologies. These factors contribute to Europe's significant presence in the adhesive for drug delivery system market. Further, the German Adhesive for Drug Delivery System market held the largest market share, and the UK Adhesive for Drug Delivery System market was the fastest growing market in the European region.
The Asia-Pacific Adhesive for Drug Delivery System Market is expected to grow at the fastest CAGR from 2024 to 2032. The Asia Pacific region is experiencing the highest compound annual growth rate (CAGR) in the market due to several factors. These include increasing diseases and expenditure, rising prevalence of chronic diseases, and expanding access to healthcare services. Additionally, rapid industrialization, technological advancements, and a growing geriatric population are driving the demand for advanced drug delivery solutions in the region. These factors collectively contribute to the robust growth of the adhesive for drug delivery system market in Asia Pacific. Moreover, China’s Adhesive for Drug Delivery System market held the largest market share, and the Indian Adhesive for Drug Delivery System market was the fastest growing market in the Asia-Pacific region.
Adhesive for Drug Delivery System Key Market Players & Competitive Insights
Leading players in the adhesive for drug delivery system market are focusing on strategic initiatives such as product launches, collaborations, and mergers to maintain their competitive edge. They are investing in research and market developments to develop innovative adhesive formulations with enhanced properties such as improved adhesion, biocompatibility, and drug release kinetics. Moreover, companies are expanding their presence through partnerships and acquisitions to tap into new markets and strengthen their market position in the rapidly evolving drug delivery system market.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Adhesive for Drug Delivery System industry to benefit clients and increase the market sector. In recent years, the Adhesive for the Drug Delivery System industry has offered some of the most significant advantages to Acrylic. Major players in the Adhesive for Drug Delivery System market, including 3M Company, Henkel AG & Co. KGaA, Avery Dennison Corporation, Scapa Group plc, Dow Inc., AdhexPharma, Corium International, Inc., Lohmann GmbH & Co. KG, ProMed Pharma, Pharmaplast AG, and Others, are attempting to increase market demand by investing in research and development operations.
3M Company is a multinational conglomerate renowned for its diverse range of innovative products across various industries, including healthcare. Within the adhesive for drug delivery system market, 3M offers a wide portfolio of adhesive solutions tailored for medical applications, including transdermal drug delivery systems. Leveraging its expertise in adhesive technology, 3M provides high-performance adhesives characterized by strong bonding, skin-friendly properties, and precise drug-release kinetics. With a presence and a strong commitment to research and development, 3M continues to drive innovation in adhesive-based drug delivery systems, catering to the evolving needs of healthcare professionals and patients worldwide.
Henkel AG & Co. KGaA is a leader in adhesive technologies and consumer goods. In the adhesive for drug delivery system market, Henkel offers a comprehensive range of innovative adhesive solutions tailored for medical applications. Leveraging its advanced research and development capabilities, Henkel develops specialized adhesives designed to meet the stringent requirements of drug delivery systems, including transdermal patches and medical tapes. With a focus on sustainability and customer-centric innovation, Henkel aims to enhance patient comfort, drug efficacy, and overall product performance. Through strategic partnerships, acquisitions, and continuous investment in technology, Henkel remains at the forefront of adhesive-based drug delivery solutions, contributing to the advancement of healthcare delivery worldwide.
Key Companies in the Adhesive for Drug Delivery System market include
Adhesive for Drug Delivery System Industry Developments
July 2022: Arkema finalized the acquisition of Permoseal, a leading provider of adhesive solutions for do-it-yourself (DIY), packaging, and construction sectors, thereby strengthening its footprint in South Africa.
July 2022: Mapei initiated the construction of its third manufacturing plant in Kosi, Mathura, aimed at meeting the growing demand from Northern India.
| Report Attribute/Metric | Details |
| Market Size 2023 | USD xx Billion |
| Market Size 2024 | USD xx Billion |
| Market Size 2032 | USD xx Billion |
| Compound Annual Growth Rate (CAGR) | 5.50% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Resin Type, Technology, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, |
| Key Companies Profiled | 3M Company, Henkel AG & Co. KGaA, Avery Dennison Corporation, Scapa Group plc, Dow Inc., AdhexPharma, Corium International, Inc., Lohmann GmbH & Co. KG, ProMed Pharma, Pharmaplast AG, and Others |
| Key Market Opportunities | · Customization for Specific Applications and Innovative Formulations |
| Key Market Dynamics | · Growing investments in research and development and Increasing Demand for Transdermal Drug Delivery |
Frequently Asked Questions (FAQ) :
The market size was valued at USD xx Billion in 2023.
The market is projected to grow at a CAGR of 5.50% during the forecast period, 2024-2032.
North America had the largest share in the market.
The key players in the market are 3M Company, Henkel AG & Co. KGaA, Avery Dennison Corporation, Scapa Group plc, Dow Inc., AdhexPharma, Corium International, Inc., Lohmann GmbH & Co. KG, ProMed Pharma, Pharmaplast AG, and Others.
The Acrylic category dominated the market in 2023.
Hydration-Mediation Adhesion had the largest share of the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
